Trials / Unknown
UnknownNCT04056260
ICG-NIR Guided Lymph Node Dissection in Gastric Cancer
Oncologic Safety of Sentinel Lymph Node-guided Lymph Node Dissection Using ICG-NIR Laparoscopy in Gastric Cancer
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 219 (estimated)
- Sponsor
- Ho Seok Seo · Academic / Other
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
As the survival rate of patients with gastric cancer has increased, there has been a growing interest in interventions that improve postoperative quality of life. Therefore minimally invasive surgery or endoscopic resection has been performed much more frequently. However, adequate lymph node dissection is important as well. The aim of the study is to identify the feasibility of indocyanine green - near infra-red (ICG-NIR) guided sentinel lymph node dissection for the treatment of gastric cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | ICG-NIR guided surgery | ICG 0.5mg/ml x 0.5ml x 4 sites injection through intra-operative endoscopy |
Timeline
- Start date
- 2020-03-20
- Primary completion
- 2020-08-31
- Completion
- 2020-12-31
- First posted
- 2019-08-14
- Last updated
- 2020-03-20
Source: ClinicalTrials.gov record NCT04056260. Inclusion in this directory is not an endorsement.